Prognosis
Prognosis is best when:
Patients are <50 years of age
The total body surface area involved is low
Patients are transferred to a burn center
Patients do not have sepsis
Patients do not require antibiotics
Patients do not have pulmonary issues.
One study of pediatric patients with SJS or TEN admitted to a US hospital between 2000 and 2007 reported that 18% had a recurrence of SJS up to 7 years after the initial episode, and 47% had long-term sequelae. The mortality rate was lower than that reported in adults.[100][101]
One retrospective study of 189 children with SJS over a 29-year period in Thailand reported complications in 20%.[102]
SJS
The majority of patients recover, although they may develop some ocular or organ complications residual to the disease; mortality is 1% to 5%.
SJS/TEN overlap
The majority of patients recover, although they may develop some complications of ocular or organ origin.
TEN
The majority of patients recover, although they may develop some ocular or organ complications residual to the disease; mortality is 25% to 35%.
In a multicenter study of 199 TEN patients, 64 died. Of the deaths, one third were due to sepsis, one third to multiple organ failure, 14% to cardiopulmonary complications, and 16% were attributed to other causes. Of the 135 survivors, 66% went home, 14% went on to rehabilitation, 7.3% went to an intermediate-care facility, and 7.3% returned to their referring physician.[103]
Use of this content is subject to our disclaimer